Müller, H; Eusterschulte, B; Havemann-Reinecke, U et al.
Forensische Aspekte des therapeutischen Drug Monitorings (TDM) in der PsychiatriePsychopharmakotherapie. Bd. 16. H. 2. 2009 S. 52-56
Tadic, A; Wagner, S; Hoch, J et al.
Gender Differences in Axis I and Axis II Comorbidity in Patients with Borderline Personality DisorderPsychopathology. Bd. 42. 2009 S. 257-263
Treutlein, J; Cichon, S; Ridinger, M et al.
Genome-wide association study of alcohol dependenceArch Gen Psychiatry. Bd. 66. H. 7. 2009 S. 773-784
Wölfling, K; Buhler, M; Lemenager, T et al.
GlücksspielNervenarzt. Bd. 80. H. 9. 2009 S. 1030-9
Scheurich, A; Fellgiebel, A
Gruppentherapeutische Behandlung bei beginnender dementieller ErkrankungZeitschrift für Neuropsychologie. Bd. 20. H. 1. 2009 S. 21-29
Becker, A; Grecksch, G; Zernig, G et al.
Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophreniaPsychopharmacology (Berl). Bd. 202. H. 4. 2009 S. 579-587
Tonn, P; Reuter, SC; Hiemke, C et al.
High mirtazapine plasma levels in infant after breast feeding - Case Report and Review of the LiteratureJ Clin Psychopharmacol. Bd. 29. H. 2. 2009 S. 191-192
Yakushev, IY; Dupont, E; Buchholz, HG et al.
In vivo imaging of dopamine receptors in a model of temporal lobe epilepsyEpilepsia. 2009 S. 1
Endres, K; Mitteregger, G; Kojro, E et al.
Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivoNeurobiol Dis. Bd. 36. H. 2. 2009 S. 233-41
Tadic, A; Victor, A; Baskaya, Ö et al.
Interaction between Gene Variants of the Serotonin Transporter Promoter Region (5-HTTLPR) and Catechol O-Methyltransferase (COMT) in Borderline Personality DisorderAm J Med Genet B Neuropsychiatr Genet. Bd. 150. H. 4. 2009 S. 478-495